Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

black woman breast cancer pink ribbon

Disparities in breast cancer detection and care persist, despite a drop in mortality, new ACS report reveals

While Black women have lower incidence of breast cancer diagnosis, their mortality rates are 40% higher than those observed in white women.  

Thumbnail

Experts share positive news for women who have undergone multiple GBCA exposures during breast MRI

Authors of the new study stated that their findings are “reassuring” for both clinicians and patients.

FAPI PET/CT shows promise as a better radiotracer for cancer than 18F-FDG. It also can be used for detection of infection and inflammation.

VIDEO: 6 key advances in molecular imaging technology for PET and SPECT

Munir Ghesani, MD, President of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), system chief of nuclear medicine at Mount Sinai Health, explains recent advances in nuclear imaging technology.

Thumbnail

New lesion measurement assesses treatment responses more accurately than RECIST

Researchers believe the new method of assessing treatment responses could pave the way for developing new cancer therapeutics.

Thumbnail

FDA clears 2D image-reconstruction product for 3D MRI

GE Healthcare may ship its deep learning-based image reconstruction software called AIR Recon DL with new 3D capabilities, the company announced Sept. 29.

Thumbnail

Transplanted lungs react to COVID in a distinctive way

Clinicians treating COVID-19 patients who have transplanted lungs and lower airway infection should order molecular testing in addition to, or regardless of, imaging findings.

Thumbnail

A new Alzheimer's drug therapy appears effective. What might this mean for the future of amyloid PET?

Previously, CMS determined that coverage for patients receiving treatment was dependent on their being enrolled in a CMS-approved clinical trial under coverage with evidence development (CED).

Thumbnail

Fetal MRI reveals how opioid use during pregnancy limits brain growth in utero

This study is one of the largest to date to assess brain growth in opioid-exposed fetuses in utero.